UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

P1361: TREATMENT OF SEVERE STEROID‐REFRACTORY ACUTE GVHD WITH MESENCHYMAL STROMAL CELLS: RESULTS OF THE PHASE III RANDOMIZED DOUBLE‐BLIND MULTI‐CENTER HOVON‐113 TRIAL

HemaSphere, 2022-06, Vol.6 (Suppl), p.1245-1246

2022

Volltextzugriff (PDF)

P837: ELTROMBOPAG (EPAG) INDUCES HEMATOLOGIC RESPONSES FOR PATIENTS WITH POST‐ALLOGENIC HEMATOPOIETIC STEM CELL TRANSPLANT POOR GRAFT FUNCTION (POST‐ALLO HSCT PGF): RESULTS OF THE ELTION STUDY IN SPAIN

HemaSphere, 2022-06, Vol.6 (Suppl), p.731-732

2022

Volltextzugriff (PDF)

Results of a prospective phase II trial with ofatumumab as part of reduced intensity conditioning regimen in high‐risk non‐Hodgkin B lymphoma patients: A GELTAMO trial

Hematological oncology, 2017-06, Vol.35 (S2), p.346-347

2017

Volltextzugriff (PDF)

29 MICROVESICLES/EXOSOMES DERIVED FROM BONE MARROW MESENCHYMAL STROMAL CELLS (MSC) ARE INVOLVED IN THE INTERCELLULAR COMMUNICATION BETWEEN HEMATOPOIETIC CELLS AND BM MICROENVIRONMENT IN MDS PATIENTS

Leukemia research, 2015-04, Vol.39, p.S12-S13

2015

Volltextzugriff (PDF)

C013 Genomic aberrations observed in mesenchymal stem cells from 5q-syndrome could be involved in the pathophysiology of the disease

Leukemia research, 2009-05, Vol.33, p.S38-S39

2009

Volltextzugriff (PDF)

VP37.14: Pregnant women with pre‐eclampsia show increased serum levels of implantation and differentiation trophoblast factors

Ultrasound in obstetrics & gynecology, 2021-10, Vol.58 (S1), p.257-257

2021

Volltextzugriff (PDF)

VP33.15: MicroRNAs profile from plasma of pregnant women with intrauterine fetal growth restriction

Ultrasound in obstetrics & gynecology, 2021-10, Vol.58 (S1), p.89-312

2021

Volltextzugriff (PDF)

Correction: Benchmarking of survival outcomes following haematopoietic stem cell transplantation: A review of existing processes and the introduction of an international system from the European Society for Blood and Marrow Transplantation (EBMT) and the Joint Accreditation Committee of ISCT and EBMT (JACIE)

Bone marrow transplantation (Basingstoke), 2020-04, Vol.55 (4), p.838-839

2020

Volltextzugriff (PDF)

201 - Mesenchymal Stem/Stromal Cells: TRANSCRIPTOMIC STUDY OF THE IMMUNOMODULATORY PROPERTIES OF TLR3-PRIMED MESENCHYMAL STEM CELLS ISOLATED FROM HUMAN BONE MARROW

Cytotherapy (Oxford, England), 2023-05, Vol.25 (6), p.S86-S86

2023

Volltextzugriff (PDF)

Mesenchymal Stem/Stromal Cells: TRANSCRIPTOMIC STUDY OF THE IMMUNOMODULATORY PROPERTIES OF TLR3-PRIMED MESENCHYMAL STEM CELLS ISOLATED FROM HUMAN BONE MARROW

Cytotherapy (Oxford, England), 2023-05, Vol.25 (6), p.S86

2023

Volltextzugriff (PDF)

Second-Line Treatment for Steroid-Refractory Graft-Versus-Host Disease with Mesenchymal Stromal Cells. A Conceptual Disease Model

VALUE IN HEALTH, 2017-10, Vol.20 (9), p.A545-A546

2017

Volltextzugriff (PDF)

Human bone marrow mesenchymal stromal cell-derived extracellular vesicles modified by enzymatic exofucosylation prevent acute graft-versus-host disease progression

Cytotherapy (Oxford, England), 2021-05, Vol.23 (5), p.S25-S26

2021

Volltextzugriff (PDF)

Iron Overload Increases Oxidative Stress and Decreases Clonogenic Capacity of Cells in MDS Patients: Can be Restored after Deferasirox Treatment?

Leukemia research, 2017-04, Vol.55, p.S161-S162

2017

Volltextzugriff (PDF)

CAR T‐CELLS ARE ARRIVING. IS ALLOGENEIC TRANSPLANT AN OBSOLETE APPROACH FOR DE NOVO/TRANSFORMED DLBCL IN THE CAR T‐CELLS ERA? LONG‐TERM FOLLOW‐UP OF A SINGLE CENTRE UNIT

Hematological oncology, 2019-06, Vol.37 (S2), p.508-509

2019

Volltextzugriff (PDF)

P1320: INCIDENCE AND IMPACT OF COMPLICATIONS OF ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION (HSCT) IN PATIENTS OVER 60 YEARS. RETROSPECTIVE EXPERIENCE OF TWO SPANISH CENTERS IN THE 2015‐2020 PERIOD

HemaSphere, 2022-06, Vol.6 (Suppl), p.1205-1206

2022

Volltextzugriff (PDF)

P1321: INCIDENCE AND IMPACT OF GRAFT‐VERSUS‐HOST DISEASE (GVHD) IN PATIENTS OVER 60 YEARS OF AGE UNDERGOING HEMATOPOIETIC STEM CELL TRANSPLANTATION (HSCT). RETROSPECTIVE EXPERIENCE OF TWO SPANISH CENTERS

HemaSphere, 2022-06, Vol.6 (Suppl), p.1206-1207

2022

Volltextzugriff (PDF)

P1322: ALLOGENEIC HEMATOPOIETIC STEM TRANSPLANTATION (HSCT) IN PATIENTS OVER 60 YEARS. RETROSPECTIVE EXPERIENCE OF TWO SPANISH CENTERS BETWEEN 2015‐2020

HemaSphere, 2022-06, Vol.6 (Suppl), p.1207-1208

2022

Volltextzugriff (PDF)

Síndromes mieloproliferativos

Medicine - programa de formación médica continuada acreditado, 2016-11, Vol.12 (21), p.1213-1223

2016

Volltextzugriff (PDF)

Mutational Status of Mesenchymal Stem Cell in Myelodysplastic Syndromes Patients

Leukemia research, 2017-04, Vol.55, p.S117-S117

2017

Volltextzugriff (PDF)

1074 - Immunotherapy: HIGH INCIDENCE OF CYTOPENIAS AFTER COMMERCIAL CAR-T CELL THERAPY IN A REAL-WORLD SETTING: UTILITY OF THE CAR-HEMATOTOX INDEX

Cytotherapy (Oxford, England), 2023-05, Vol.25 (6), p.S248-S250

2023

Volltextzugriff (PDF)

Immunotherapy: HIGH INCIDENCE OF CYTOPENIAS AFTER COMMERCIAL CAR-T CELL THERAPY IN A REAL-WORLD SETTING: UTILITY OF THE CAR-HEMATOTOX INDEX

Cytotherapy (Oxford, England), 2023-05, Vol.25 (6), p.S248-S250

2023

Volltextzugriff (PDF)

Results of a prospective phase II trial with ofatumumab as part of reduced intensity conditioning regimen in high‐risk non‐ H odgkin B lymphoma patients: A GELTAMO trial

Hematological oncology, 2017-06, Vol.35 (S2), p.346-347

2017

Volltextzugriff (PDF)

P36 - Topic: AS04-MDS Biology and Pathogenesis/AS04i-Microenvironment and stem cell niche: MESENCHYMAL STROMAL CELLS MAY ENHANCE RESIDUAL HEALTHY HAEMATOPOIESIS IN LOW-RISK MDS PATIENTS

Leukemia research, 2021-09, Vol.108

2021

Volltextzugriff (PDF)

1 – 25 von 96

Suche als RSS-Feed

Aktive Filter

ThemaLife Sciences & Biomedicine

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(84)
Mit Volltextzugriff
(60)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(31)
Female
(18)
Male
(18)
Adult
(17)
Middle Aged
(11)
Adolescent
(8)
Child
(8)
Aged
(7)
Spain
(6)
Glycoproteins - Blood
(5)
Hematology, Oncology And Palliative Medicine
(5)
Stem Cells
(5)
Treatment Outcome
(5)
Allergens - Immunology
(4)
Animals
(4)
Biological And Medical Sciences
(4)
Bone Marrow
(4)
Medical Sciences
(4)
Mesenchymal Stem Cells
(4)
Allergens - Administration & Dosage
(3)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

P1361: TREATMENT OF SEVERE STEROID‐REFRACTORY ACUTE GVHD WITH MESENCHYMAL STROMAL CELLS: RESULTS OF THE PHASE III RANDOMIZED DOUBLE‐BLIND MULTI‐CENTER HOVON‐113 TRIAL

P837: ELTROMBOPAG (EPAG) INDUCES HEMATOLOGIC RESPONSES FOR PATIENTS WITH POST‐ALLOGENIC HEMATOPOIETIC STEM CELL TRANSPLANT POOR GRAFT FUNCTION (POST‐ALLO HSCT PGF): RESULTS OF THE ELTION STUDY IN SPAIN

Results of a prospective phase II trial with ofatumumab as part of reduced intensity conditioning regimen in high‐risk non‐Hodgkin B lymphoma patients: A GELTAMO trial

29 MICROVESICLES/EXOSOMES DERIVED FROM BONE MARROW MESENCHYMAL STROMAL CELLS (MSC) ARE INVOLVED IN THE INTERCELLULAR COMMUNICATION BETWEEN HEMATOPOIETIC CELLS AND BM MICROENVIRONMENT IN MDS PATIENTS

P756: ALLOGENEIC STEM CELL TRANSPLANTATION IN MYELODYSPLASTIC SYNDROME/MYELOPROLIFERATIVE NEOPLASM (MDS/MPN) OVERLAP SYNDROMES. A SINGLE CENTER EXPERIENCE AND DISSECTION OF MUTATIONAL PROFILE

C013 Genomic aberrations observed in mesenchymal stem cells from 5q-syndrome could be involved in the pathophysiology of the disease

VP37.14: Pregnant women with pre‐eclampsia show increased serum levels of implantation and differentiation trophoblast factors

VP33.15: MicroRNAs profile from plasma of pregnant women with intrauterine fetal growth restriction

201 - Mesenchymal Stem/Stromal Cells: TRANSCRIPTOMIC STUDY OF THE IMMUNOMODULATORY PROPERTIES OF TLR3-PRIMED MESENCHYMAL STEM CELLS ISOLATED FROM HUMAN BONE MARROW

Mesenchymal Stem/Stromal Cells: TRANSCRIPTOMIC STUDY OF THE IMMUNOMODULATORY PROPERTIES OF TLR3-PRIMED MESENCHYMAL STEM CELLS ISOLATED FROM HUMAN BONE MARROW

Second-Line Treatment for Steroid-Refractory Graft-Versus-Host Disease with Mesenchymal Stromal Cells. A Conceptual Disease Model

Human bone marrow mesenchymal stromal cell-derived extracellular vesicles modified by enzymatic exofucosylation prevent acute graft-versus-host disease progression

Iron Overload Increases Oxidative Stress and Decreases Clonogenic Capacity of Cells in MDS Patients: Can be Restored after Deferasirox Treatment?

CAR T‐CELLS ARE ARRIVING. IS ALLOGENEIC TRANSPLANT AN OBSOLETE APPROACH FOR DE NOVO/TRANSFORMED DLBCL IN THE CAR T‐CELLS ERA? LONG‐TERM FOLLOW‐UP OF A SINGLE CENTRE UNIT

P1320: INCIDENCE AND IMPACT OF COMPLICATIONS OF ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION (HSCT) IN PATIENTS OVER 60 YEARS. RETROSPECTIVE EXPERIENCE OF TWO SPANISH CENTERS IN THE 2015‐2020 PERIOD

P1321: INCIDENCE AND IMPACT OF GRAFT‐VERSUS‐HOST DISEASE (GVHD) IN PATIENTS OVER 60 YEARS OF AGE UNDERGOING HEMATOPOIETIC STEM CELL TRANSPLANTATION (HSCT). RETROSPECTIVE EXPERIENCE OF TWO SPANISH CENTERS

P1322: ALLOGENEIC HEMATOPOIETIC STEM TRANSPLANTATION (HSCT) IN PATIENTS OVER 60 YEARS. RETROSPECTIVE EXPERIENCE OF TWO SPANISH CENTERS BETWEEN 2015‐2020

Síndromes mieloproliferativos

Mutational Status of Mesenchymal Stem Cell in Myelodysplastic Syndromes Patients

1074 - Immunotherapy: HIGH INCIDENCE OF CYTOPENIAS AFTER COMMERCIAL CAR-T CELL THERAPY IN A REAL-WORLD SETTING: UTILITY OF THE CAR-HEMATOTOX INDEX

Immunotherapy: HIGH INCIDENCE OF CYTOPENIAS AFTER COMMERCIAL CAR-T CELL THERAPY IN A REAL-WORLD SETTING: UTILITY OF THE CAR-HEMATOTOX INDEX

Results of a prospective phase II trial with ofatumumab as part of reduced intensity conditioning regimen in high‐risk non‐ H odgkin B lymphoma patients: A GELTAMO trial

PS1186 CURRENT DOSE RECOMMENDATIONS FOR PONATINIB IN CHRONIC MYELOID LEUKEMIA PATIENTS CAN DIMINISH ADVERSE EVENTS WHILE MAINTAINING EFFICACY

P36 - Topic: AS04-MDS Biology and Pathogenesis/AS04i-Microenvironment and stem cell niche: MESENCHYMAL STROMAL CELLS MAY ENHANCE RESIDUAL HEALTHY HAEMATOPOIESIS IN LOW-RISK MDS PATIENTS

Aktive Filter

Suchergebnisse filtern